Cargando…
Peptidomimetic Small-Molecule Inhibitors of 3CLPro Activity and Spike–ACE2 Interaction: Toward Dual-Action Molecules against Coronavirus Infections
[Image: see text] The development of molecules able to target protein–protein interactions (PPIs) is of interest for the development of novel therapeutic agents. Since a high percentage of PPIs are mediated by α-helical structure at the interacting surface, peptidomimetics that reproduce the essenti...
Autores principales: | Tedesco, Filomena, Calugi, Lorenzo, Lenci, Elena, Trabocchi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454270/ https://www.ncbi.nlm.nih.gov/pubmed/36039955 http://dx.doi.org/10.1021/acs.joc.2c01047 |
Ejemplares similares
-
Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
por: Paul, Abhik, et al.
Publicado: (2021) -
Identification of a short ACE2-derived stapled peptide targeting the SARS-CoV-2 spike protein
por: Calugi, Lorenzo, et al.
Publicado: (2023) -
Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022) -
Occurrence of Morpholine in Central Nervous System
Drug Discovery
por: Lenci, Elena, et al.
Publicado: (2021) -
Diversity-Oriented Synthesis and Chemoinformatic Analysis of the Molecular Diversity of sp(3)-Rich Morpholine Peptidomimetics
por: Lenci, Elena, et al.
Publicado: (2018)